Medications can significantly affect oral health, influencing salivary function, gingival tissues, oral mucosa, taste perception, and susceptibility to infection.
📌 Recommended Article :
Dental Article 🔽 Medications and Developing Teeth: Dental Risks, Mechanisms, and Prevention in Children ... Understanding how specific medications affect dental development is crucial for pediatricians, dentists, and caregivers to make informed decisions and prevent long-term oral health issues.Although many drug-related oral adverse effects are mild or reversible, others may contribute to dental caries, periodontal complications, mucosal lesions, and impaired wound healing.
Advertisement
Recognizing these effects is essential for dental professionals because medication-related changes may be mistaken for primary oral diseases. A comprehensive medication history, clinical examination, and collaboration with the prescribing physician can help identify potential causes and guide appropriate management.
📌 Recommended Article :
Dental Article 🔽 Nicotine Stomatitis: Effects of Tobacco on the Oral Cavity ... Nicotine stomatitis, also known as smoker’s palate or stomatitis nicotina, is a characteristic reactive lesion of the palatal mucosa associated primarily with chronic tobacco smoking.✅ Which Medications Affect Oral Health?
The following table summarizes common medication classes, their principal oral adverse effects, and their clinical relevance.
| Medication Class | Oral Adverse Effects | Clinical Significance |
|---|---|---|
| Antidepressants and anticholinergics | Xerostomia and reduced salivary flow. | Increased risk of caries, oral discomfort, and swallowing difficulties. |
| Antihypertensives, particularly calcium channel blockers | Gingival overgrowth, especially with nifedipine and amlodipine. | Plaque retention, bleeding, and periodontal complications. |
| Anticoagulants and antiplatelet agents | Increased bleeding tendency. | Relevant to extractions, periodontal surgery, and other invasive procedures. |
| Bisphosphonates and denosumab | Risk of medication-related osteonecrosis of the jaw (MRONJ). | Important when planning extractions and other procedures involving bone. |
| Immunosuppressants and chemotherapy agents | Mucositis, ulceration, infections, and delayed healing. | May complicate oral hygiene, eating, and invasive dental treatment. |
| Inhaled corticosteroids | Oral candidiasis, dysphonia, and throat irritation. | Risk may be reduced by rinsing the mouth after inhalation and using appropriate inhaler technique. |
| Antiepileptic drugs, particularly phenytoin | Gingival enlargement. | May interfere with plaque control and periodontal health. |
| Antibiotics, especially tetracyclines during tooth development | Intrinsic tooth discoloration with certain agents. | Tetracycline exposure during tooth development may cause permanent discoloration. |
Beyond the most recognized drug reactions, several additional manifestations are clinically relevant:
▪️ Taste disturbances (dysgeusia): reported with certain antibiotics, antihypertensives, and other medications.
▪️ Oral lichenoid reactions and mucosal ulceration: may occur with selected medications, including some antihypertensive and anti-inflammatory agents. A persistent lesion requires appropriate diagnostic assessment.
▪️ Increased caries susceptibility: medication-induced hyposalivation reduces the protective and buffering functions of saliva, promoting demineralization and caries development.
▪️ Oral candidiasis: associated with inhaled corticosteroids and immunosuppressive treatments, particularly when additional risk factors are present.
▪️ Delayed healing and jaw osteonecrosis: require particular attention in patients receiving antiresorptive or certain oncology therapies. The risk of MRONJ varies with the drug, indication, treatment intensity, and individual risk factors.
📌 Recommended Article :
Dental Article 🔽 Oral Contraceptives and Oral Health Effects ... The use of oral contraceptives (OCs) has been associated with multiple changes in the oral cavity, particularly affecting gingival tissues, salivary composition, and periodontal health.✅ How Should Dentists Manage Medication-Related Oral Effects?
Management should focus on identifying the suspected drug effect, controlling oral complications, and coordinating care with the prescribing clinician.
1. Review the medication history. Document prescription drugs, over-the-counter products, supplements, recent changes, and treatment duration.
2. Assess salivary function and caries risk. For patients with xerostomia, consider hydration, sugar-free salivary stimulants, saliva substitutes, and individualized caries-prevention measures.
3. Control plaque and gingival inflammation. Professional periodontal maintenance and effective home care are particularly important in drug-induced gingival enlargement.
4. Evaluate bleeding risk before invasive treatment. Most patients taking anticoagulants or antiplatelet agents can undergo many dental procedures without discontinuing therapy; decisions must be individualized, with local hemostatic measures and medical consultation when indicated. Do not advise patients to stop these medications independently.
5. Plan care for patients receiving antiresorptive therapy. Review the indication, medication history, and procedural risks before extractions or other bone-invasive procedures. Medication interruption should not be recommended routinely without coordinated, individualized assessment.
📌 Recommended Article :
Dental Article 🔽 Top 5 Antibiotics Used in Dentistry and Their Indications ... Current evidence emphasizes source control through procedures such as drainage, pulpotomy, pulpectomy, or root canal treatment rather than routine antibiotic prescribing.💬 Discussion
Medication-related oral disorders represent an important component of differential diagnosis in dental practice. Xerostomia, gingival enlargement, mucosal lesions, bleeding, and impaired healing may be associated with pharmacological treatment, but their presence does not automatically establish a drug-induced cause. Underlying systemic disease, oral hygiene, dosage, polypharmacy, and individual susceptibility may also contribute.
The clinical priority is to distinguish a suspected adverse drug reaction from an unrelated or coexisting oral disease. Appropriate assessment can prevent unnecessary treatment, support early intervention, and improve long-term oral health. Medication changes should be coordinated with the prescribing clinician rather than undertaken solely on the basis of dental findings.
🎯 Clinical Recommendations
▪️ Prioritize medication reconciliation during initial assessment and before invasive procedures, particularly in patients with polypharmacy.
▪️ Establish a preventive recall schedule according to individual caries, periodontal, and mucosal risk rather than medication exposure alone.
▪️ Investigate persistent, unexplained oral ulceration, swelling, or mucosal changes; consider specialist referral or biopsy when indicated.
▪️ Document suspected adverse reactions and coordinate any proposed medication modification with the prescribing clinician.
✍️ Conclusion
Several commonly prescribed medications can affect salivary function, gingival tissues, oral mucosa, bleeding control, and jawbone healing. Identifying these associations allows dental professionals to recognize potential adverse effects, tailor preventive strategies, and plan treatment more safely. A systematic medication history and evidence-based, individualized care remain essential to minimizing oral complications without compromising the management of systemic disease.
📚 References
✔ American Dental Association. (n.d.). Oral anticoagulant and antiplatelet medications and dental procedures. https://www.ada.org/resources/ada-library/oral-health-topics/oral-anticoagulant-and-antiplatelet-medications-and-dental-procedures
✔ American Dental Association. (n.d.). Osteoporosis medications and medication-related osteonecrosis of the jaw. https://www.ada.org/resources/ada-library/oral-health-topics/osteoporosis-medications
✔ National Institute of Dental and Craniofacial Research. (2024). Dry mouth. National Institutes of Health. https://www.nidcr.nih.gov/health-info/dry-mouth
✔ Ruggiero, S. L., Dodson, T. B., Aghaloo, T., Carlson, E. R., Ward, B. B., & Kademani, D. (2022). American Association of Oral and Maxillofacial Surgeons’ position paper on medication-related osteonecrosis of the jaws—2022 update. Journal of Oral and Maxillofacial Surgery, 80(5), 920–943. https://doi.org/10.1016/j.joms.2022.02.008
✔ Scully, C. (2003). Drug effects on salivary glands: Dry mouth. Oral Diseases, 9(4), 165–176. https://doi.org/10.1034/j.1601-0825.2003.03967.x
✔ Scully, C., & Bagan, J.-V. (2004). Adverse drug reactions in the orofacial region. Critical Reviews in Oral Biology & Medicine, 15(4), 221–239. https://doi.org/10.1177/154411130401500405
📌 More Recommended Items
► Clindamycin for Odontogenic Infections: Risks & Uses
► Medications That Interfere With Orthodontics: Clinical Guide
► Persistent Oral Ulcers: Warning Signs You Shouldn't Ignore


.jpg)

